Indications for use
- The regular treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting beta2-agonist) is appropriate
- Symptomatic treatment of patients with severe COPD and a history of repeated exacerbations, who have significant symptoms despite regular therapy with long-acting bronchodilators.